Pharmaceutical company Moderna announced that its lead vaccine candidate is nearly 95% effective based on an early analysis from an independent board.

“This is a pivotal moment in the development of our COVID-19 vaccine candidate,” Moderna CEO Stephane Bancel said on Monday. “This milestone is only possible because of the hard work and sacrifices of so many.”

Recommended Stories

Moderna to ask FDA for emergency use authorization

Coronavirus vaccine will begin arriving in states Monday: US government

COVID-19 vaccine technology holds promise for producing HIV vaccine